ANTI-TUMOR NECROSIS FACTOR AGENTS MAY PREVENT CARTILAGE LOSS OF HIP IN PATIENTS WITH ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Lee, S. H. [1 ]
Song, R. [1 ]
Lee, Y. A. [2 ]
Hong, S. J. [2 ]
Yang, H., I [1 ]
机构：
[1] Kyung Hee Univ, Hosp Gang Dong, Dept Rheumatol, Seoul, South Korea
[2] Kyung Hee Univ, Med Ctr, Dept Rheumatol, Seoul, South Korea
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [31] Profile of Use of Anti-Tumor Necrosis Factor (Anti-TNF) Agents and Disease Modifying Anti Rheumatic Drugs (DMARD) in Ankylosing Spondylitis Patients in a Brazilian Healthcare Database
    Machado, Marina A. A.
    Ferre, Felipe
    Moura, Cristiano S.
    Almeida, Alessandra M.
    Andrade, Iola G.
    Cherchiglia, Mariangela A.
    Guerra Junior, Augusto A.
    Acurcio, Francisco A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 482 - 482
  • [32] Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis
    Dulgeroglu Erdogdu, Deniz
    Bal, Ajda
    Karaahmet, Ozgur
    Erkoc, Sibel
    Yalcin, Tugba
    Cakci, Aytul
    [J]. ARCHIVES OF RHEUMATOLOGY, 2014, 29 (04) : 257 - 266
  • [33] TUMOR NECROSIS FACTOR BLOCKING AGENTS INHIBIT THE PROGRESSION OF PRECLINICAL ATHEROSCLEROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Van Sijl, A. M.
    van Eijk, I. C.
    Peters, M. J.
    Serne, E. H.
    van der Horst-Bruinsma, I. H.
    Smulders, Y. M.
    Nurmohamed, M. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 519 - 519
  • [34] Inhibition of tumor necrosis factor α and ankylosing spondylitis
    Asli, B
    Wechsler, B
    Lemaître, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (04): : 359 - 360
  • [35] Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitors
    Ma, Kevin Sheng-Kai
    Kao, Pei-En
    Chen, Kun-Hui
    Liu, Chin-Hsiu
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1412 - 1413
  • [36] EFFECT OF ANTI-TUMOR NECROSIS FACTOR-A THERAPIES ON WEIGHT AND BODY MASS INDEX IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Senturk, T.
    Cildag, S.
    Akdam, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 875 - 876
  • [37] Effects of anti-tumor necrosis factor a agents on bone
    Kawai, Vivian K.
    Stein, C. Michael
    Perrien, Daniel S.
    Griffin, Marie R.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (05) : 576 - 585
  • [38] Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis
    Wu, Dan
    Guo, Ying-Ying
    Xu, Nan-Nan
    Zhao, Shuai
    Hou, Lin-Xin
    Jiao, Ting
    Zhang, Ning
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [39] Anti-Tumor Necrosis Factor Therapies Reduce Serum Macrophage Inflammatory Protein-1α in Ankylosing Spondylitis
    Akbulut, Handan
    Koca, Suleyman S.
    Ozgen, Metin
    Isik, Ahmet
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1073 - 1074
  • [40] Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
    Konsta, Maria
    Nurmohamed, Michael T.
    Iliopoulos, Alexios
    Sfikakis, Petros P.
    van Denderen, J. Christiaan
    Visman, Ingrid
    Sakelariou, Grigorios T.
    van der Horst-Bruinsma, Irene E.
    [J]. JOURNAL OF RHEUMATOLOGY, 2023, 50 (03) : 342 - 350
12345